Clinical TrialsSearch results
Number of results: 861
Recruiting
- Avacopan vs reduced-dose glucocorticoids ANCA-associated vasculitis; non-inferiority study
- Newly onset microscopic polyangiitis (MPA) or granulomatosis with polyangiitis (GPA)
- Harigai Masayoshi
- 2024-11-18
Recruiting
- Development of Novel Urinary Biomarkers in Patients with Renal Disease
- Overall renal disease and healthy volunteers
- Wakabayashi Hanae
- 2024-11-18
Not yet recruiting
- The Efficacy of Hemo-Quic
- Non-cardiac surgery
- Ueda Kenichi
- 2024-11-07
Not yet recruiting
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Colorectal Neoplasms
- Nakama Takahiro
- 2024-11-05
Not yet recruiting
- Clinical study for optimizing human intestinal preparation protocols to assess intestinal mucosal secretory IgA antibody titers.
- Healthy subjects
- Kato Naoya
- 2024-11-05
Recruiting
- JCOG2311: A randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for metastatic esophageal cancer
- Esophageal cancer
- TSUSHIMA Takahiro
- 2024-11-05
Recruiting
- Verification of the Effects of Post-Exercise Stress Relief Methods on Physical and Mental Well-Being
- Since this experiment was conducted on healthy subjects, there were no target diseases.
- Nakai Sadamu
- 2024-11-05
Recruiting
- HN Multi-ions LETd escalation study
- head and neck cancer
- Shinoto Makoto
- 2024-10-31
Recruiting
- Safety/Efficacy Evaluation of Live Influenza Vaccine in Patients Receiving Dupilumab
- Pediatric patient with atopic dermatitis on Dupilumab treatment
- Nagasawa Koo
- 2024-10-30
Recruiting
- JCOG2302: Randomized phase III trial comparing nivolumab therapy and S-1 therapy in the second-line treatment of non-small cell lung cancer with interstitial pneumonitis
- Advanced non-small cell lung cancer without driver gene alteration
- Kogure Yoshihito
- 2024-10-25